THE GLOBAL SLEEP APNEA DEVICES MARKET SIZE IS EXPECTED TO REACH USD 10 BILLION BY 2027 FROM USD 6.74 BILLION IN 2021, GROWING AT A CAGR OF 7.07% DURING THE FORECAST PERIOD

The Global Sleep Apnea Devices Market Size, Share, & Trends Analysis Report By

  • Product: Therapeutic Devices, Facial Interfaces, and Diagnostics Devices
  • Age Group: Between 41 & 60 Years, 61 Years & Above, and Below 40 Years
  • Gender: Males and Females
  • End-User: Sleep Clinics/Labs, Home Healthcare Settings, Hospitals, and Others
  • Geography: North America, Europe, APAC, Latin America, and Middle East & Africa

Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022–2027

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

341 Pages

icon-table

179 Tables

icon-chart

157 Charts

icon-region

5 Regions

icon-country

18 Countries

icon-company

36 Companies

icon-market

5 Market Segment

SLEEP APNEA DEVICES MARKET REPORT SCOPE

Report Attribute Details
Market Size (2027) USD 10.16 Billion
Market Size (2021) USD 6.74 Billion
CAGR (2021-2027) 7.07%
Base Year 2021
Forecast Year 2022-2027
Market Segments Product, Age Group, Gender, End-user, and Geography
Geographic Analysis North America, Europe, APAC, Latin America, and Middle East & Africa
KEY VENDORS Nihon Kohden Corporation, BMC Medical, Drive DeVilbiss Healthcare, SomnoMed, Glidewell, ResMed, Koninklijke Philips N.V, Fisher & Paykel Healthcare, Compumedics Limited, Inspire Medical Systems, Natus Medical, and Itamar Medical

The global sleep apnea devices market was valued at USD 6.74 billion in 2021 and is expected to reach USD 10 billion by 2027, growing at a CAGR of 7.07%. The growing sleep apnea devices market is attributed to factors such as the high prevalence of sleep apnea, increasing potential risk factors, technological advancements in sleep apnea devices, and an increasingly aging population. Obstructive sleep apnea (OSA) is particularly prevalent in adults with mild to moderate severity (14% in men and 5% in women) and is becoming more common, partly due to the increasing prevalence of obesity worldwide. The global prevalence of OSA is estimated at 1 billion people, and in some countries, the prevalence in the general population is estimated to exceed 50%.

In developed regions such as North America and Europe, sleep apnea devices are already widely held for OSA. The sleep apnea devices market in these regions is witnessing the entry of many new players and start-ups, promising to provide different products that meet customer demand and market trends. The current trend is smart sleep apnea devices, which are being explored by existing and new players in the market.

The increasing prevalence of obesity and other lifestyle diseases in both developed and developing countries and the rising rate of diagnosis of sleep apnea is presenting a larger patient demographic which requires treatment or management of sleep apnea. This, combined with the increasing number of sleep physicians, technicians, and sleep clinics globally, is facilitating the global sleep apnea devices market's growth.

MARKET TRENDS & OPPORTUNITIES

The Emergence of Artificial Intelligence in Sleep Apnea Treatment

  • The convergence of large data sets, increased computing power, and algorithm advances have opened the door to Artificial intelligence (AI) applications across various industries.
  • AHI is only a consideration, and the ability to predict side effects and response to treatment is limited. AI offers the opportunity to consider more factors than AHI. AHI provides more information about the severity and OSA endophenotype and can influence treatment choices.
  • Artificial intelligence (AI) will pave the way for screening and diagnosing OSA, reduce costly PSG deployment, and streamline the path to effective treatment in the sleep apnea devices market.

Growing Demand and Advancements in Home Sleep Apnea Tests (HSATs)

  • In December 2007, the American Academy of Sleep Medicine (AASM) task force published guidelines for the use of unattended wearable monitors (PM) for the diagnosis of obstructive sleep apnea (OSA) in adults. In March 2017, considering recent technological advances in the sleep apnea devices market, the AASM revised its guidelines to include home sleep testing (HST) measuring peripheral arterial tonometry (PAT), oximetry, and actigraphy in obstructive sleep.
  • Itamar Medical, a leading player in the sleep apnea diagnostics market, offers WatchPat, the market-leading sleep apnea diagnostic device that uses this proprietary PAT technology.
  • ResMed launches a three-part "Onesleeptest" service for NightOwl after acquiring the device’s manufacturer Ectosense. The onesleeptest device accurately tracks and delivers results from a certified sleep specialist within 3-5 business days, making it the ideal solution for testing sleep quality from the comfort and safety of their own home during the pandemic.

Technological Advancements in Continuous Positive Airway Pressure (CPAP) Therapy

  • CPAP has changed significantly since its inception in 1981. Devices developed decades ago were heavier, noisier, and had limited performance compared to today's slim, lightweight devices.
  • An outstanding innovation is the Automatic Airway Pressure Device (AutoPAP); with AutoPAP, airway pressure begins with light to meet lower pressure needs. When a patient falls asleep, the device automatically adjusts to increase positive airway pressure and keep the respiratory system open. Some CPAP machines in the sleep apnea devices market have the intellectual ability to record the mask on time when the patient breathes into the mask, when the air supply is started and when the mask is removed, and the air stops.
  • Another notable feature of CPAP today is its low noise level. In addition to size and weight, the CPAP machine's ability to deliver 20 cm H2O-filtered air to patients with a slight humping is just as refreshing for doctors, patients, and bed partners. The days of sleeping next to mechanically generated hurricanes are over; thanks to a lightweight blower, it is well insulated with CPAP machines.

SEGMENTATION INSIGHTS

PRODUCTS INSIGHTS
The therapeutic devices segment accounts for the highest share of 73.98% in the global sleep apnea devices market by products segment. The therapeutics device segment comprises positive airway pressure (PAP) devices, oral appliances, adaptive servo-ventilators, implants, airway clearance systems, oxygen therapy devices, & accessories. The prevalence of OSA is increasing significantly in developed and developing countries. The prevalence of OSA is rising due to the exponentially growing potential risk factors such as obesity, the aging population, smoking, a sedentary lifestyle, etc. Positive airway pressure (PAP) therapy is a common term used for all sleep apnea treatments that use compressed air flow to support the airways during sleep. The PAP machines continuously witness technological advancements; for instance, these devices combine the variable positive air pressure (VPAP), a relatively new technology, with the automatic adjustments of classic BiPAP therapy's dual-level pressure settings.

The global sleep apnea devices market by facial interfaces was valued at USD 916.7 million in 2021. Continuous positive airway pressure (CPAP) masks and headgear are available in various styles and sizes to help treat sleep apnea. Because everyone's needs, preferences, and face shapes are different, patients may need to try different mask styles before finding the one that works best for them. A mask is used to direct air through the therapy device. Most masks have built-in vents to expel exhaled air.

AGE GROUP INSIGHTS
The global sleep apnea devices market by age group is segmented into between 41 & 60 years, 61 years & above, and below 40 years. Between 41 & 60 years accounted for a larger share, 51.06% in the global market. The 41-60 years of the age group of people are the working adult population facing daily issues from the workplace to the home. The major risk factors for developing OSA and its related symptoms, like snoring in this age group, are work-related stress, alcohol consumption, chronic smoking, and obesity.

GENDER INSIGHTS
The male segment accounted for the highest share of 60.50% in the global sleep apnea devices market by gender segment. OSA is the usual sleep-related breathing disorder, and it is most common in older males. In North America, the estimated prevalence is about 15-30% in males. Most patients with OSA complain of daytime sleepiness or report loud snoring, wheezing, choking, sniffling, or cessation of breathing while their bed partner sleeps. These symptoms are often identified during assessment for another condition, wellness maintenance, or preoperative screening. Women report greater reporting of OSA symptoms for their bed partners. Obesity is a significant risk factor for sleep apnea, and most OSA patients are overweight. Men are more likely than women to increase AHI for a given weight gain, regardless of baseline weight, waist size, age, or race. The global male sleep apnea devices market is expected to grow at a CAGR of 7.30% during the forecast period.

END-USER INSIGHTS
Among all end-users, the sleep clinics/labs segment accounted for the highest share of 39.14% in the global sleep apnea devices market. With the increasing prevalence of sleep disorders, the requirement for sleep labs is also rising. Accurate diagnosis is essential for the determination of sleeping disorders. Because of higher medical accuracy, polysomnography (PSG) is the most preferred technology for diagnosis.

With the increasing incidences of sleeping disorders, the demand for sleep facilities and clinics equipped with technologically advanced PSGs is increasing. Nearly 3,500 sleep labs or clinics have been established across the US since they began in the 1970s. The American Academy of Sleep Medicine has accredited about 1,400 of these facilities. The need for these facilities is supported by research; recent findings relate sleep disturbances to an increased risk of heart attack, stroke, diabetes, rheumatoid arthritis, metabolic disorders, and other illnesses.

GEOGRAPHICAL INSIGHTS

The global sleep apnea devices market is categorized into regions of North America, Europe, APAC, Latin America, and the Middle East & Africa. In 2021, North America dominated the global market and accounted for a revenue share of 40.43%. The region's market growth depends on various factors, including a high prevalence of sleep disorders, a decrease in sleep patterns, lifestyle changes, and the presence of various vendors, including key players, start-ups, and sleep-based companies. The region has witnessed a high prevalence of OSA; for instance, the prevalence of OSA in North America is nearly 15 to 30% in men and 10 to 15% in women. The presence of sleep apnea device manufacturers boosts the region's market share, making it more significant than any other region globally.

Europe's sleep apnea devices market was valued at USD 1.9 billion in 2021. In Europe, the market is driven by the growing use of technology to manage sleep disorders. Technology, such as PAP devices, innovative OAT devices, and diagnostics devices, is getting traction in the European market. APAC proves to be the region with the fastest growth rate among other regions. It is expected to continue its growth during the forecast period and affect the global sleep apnea devices market with its power to manufacture large-scale products. China, Japan, and India are the leading countries in the APAC sleep apnea device, where China is dominating the sleep apnea devices market with its innovative solutions.

VENDOR LANDSCAPE

The global sleep apnea devices market is highly diversified, with several global and local players offering a diverse range of sleep apnea devices such as PAP devices, oral devices, implants, and other devices. The global players focus on developing innovative products and expanding their product portfolio to remain competitive. They are investing extensively in R&D and product development activities to expand their product portfolio. Manufacturers in the global sleep apnea devices market, such as ResMed, Koninklijke Philips N.V, BMC Medical Natus Medical, Itamar Medical, inspire medical system, Compumedics, and Drive DeVilbiss Healthcare, are continuously focusing on product development and offering sophisticated sleep apnea device with new technology to increase their industry presence.

Recent Advancements In The Global Sleep Apnea Devices Market

  • In April 2022, Fisher & Paykel Healthcare announced the launch of the F&P Evora Full in the US, a compact full-face mask for OSA.
  • In June 2021, Oventus Medical signed a partnership agreement with Aeroflow Healthcare to bring Oventus' OSA treatment solutions, including O2Vent Optima, directly to consumers through US sleep clinics.
  • In August 2021, ResMed launched a new PAP device in the US sleep apnea devices market to help hundreds of millions of people with sleep apnea.
  • In February 2021, Oventus Medical launched 02Vent Optima, a customizable oral appliance therapy device that offers an alternative to CPAP therapy through GoPAPfree in the US.
  • In December 2021, ZOLL Medical Corporation, a subsidiary of Asahi Kasei that manufactures medical devices and related software solutions, announced the acquisition of Itamar Medical Ltd., a medical device and digital health company that provides home testing services.

Frequently Asked Questions

How big is the sleep apnea market?

The global sleep apnea devices market size was valued at USD 6.74 billion in 2021 and is expected to reach USD 10 billion by 2027.

What is the growth rate of the global sleep apnea devices market?

The global sleep apnea devices market is growing at a CAGR of 7.07% from 2021-2027.

What are the rising trends in the sleep apnea devices market?

The emergence of artificial intelligence in sleep apnea treatment, growing demand & advancement in-home sleep apnea tests (HSATs), increasing adoption of telemedicine, mHealth (Mobile Health) in sleep apnea treatment, and rising popularity of Non-CPAP devices for sleep apnea treatment are the growing trends in the global sleep apnea devices market.

Which are the key companies in the global sleep apnea devices market?

Nihon Kohden Corporation, BMC Medical, Drive DeVilbiss Healthcare, SomnoMed, Glidewell, ResMed, Koninklijke Philips N.V, Fisher & Paykel Healthcare, Compumedics Limited, Inspire Medical Systems, Natus Medical, Itamar Medical are the key vendors in the global sleep apnea devices market.

Which are the popular CPAP devices available in the market?

Resmed Airsense 10 CPAP, Z2 Auto Travel CPAP Machine, Resmed Airmini Autoset Travel CPAP Machine, and Devilbiss Intellipap 2 Auto Adjust CPAP are the popular CPAP devices available in the sleep apnea devices market.

Which holds the most significant global sleep apnea devices market share?

North America dominates the global sleep apnea devices market with a 40.43% share. The US is the largest revenue generator country in the North American region due to lifestyle changes and the sedentary lifestyle of the country.

Download Free Sample

The sleep apnea devices market is expected to grow at a CAGR of approximately 7.07% from 2022 to 2027.

The following factors are likely to contribute to the growth of the sleep apnea devices market during the forecast period:

  • Improvements in Sleep Apnea Diagnosis
  • Technological Advancements in Continuous Positive Airway Pressure (CPAP) Therapy
  • Increasing Target Patient Population
  • High Growth Potential for Upper Airway Stimulation Therapy (Implant) System

Base Year: 2021

Forecast Year: 2022-2027

The report considers the present scenario of the sleep apnea devices market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.

Key Company Profiles

  • Nihon Kohden Corporation
    • Business Overview
    • Product Offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  • BMC Medical
  • Drive DeVilbiss Healthcare
  • SomnoMed
  • Glidewell
  • ResMed
  • Koninklijke Philips N.V
  • Fisher & Paykel Healthcare
  • Compumedics Limited
  • Inspire Medical Systems
  • Natus Medical
  • Itamar Medical

Other Prominent Vendors

  • Apex Medical
    • Business Overview
    • Product Offerings
  • Cadwell Industries
  • SOMNOmedics
  • Cleveland Medical Devices
  • ProSomnus Sleep Technologies
  • MEDITAS
  • White Dental Healthcare
  • Oventus
  • Tomed
  • Signifier Medical Technologies
  • ApneaMed
  • Nyxoah
  • Vivos Therapeutics
  • Somnowell
  • RemSleep Holdings
  • Siesta Medical
  • Horizon Prime
  • Nox Medical
  • Onera Health
  • LivaNova
  • ZOLL Medical
  • BRAEBON Medical
  • Invacare
  • Breas Medical

Segmentation by Product:

  • Therapeutic Devices
  • Facial Interfaces
  • Diagnostics Devices

Segmentation by Age Group:

  • Between 41 & 60 Years
  • 61 Years & Above
  • Below 40 Years

Segmentation by Gender:

  • Males
  • Females

Segmentation by End-User:

  • Sleep Clinics/Labs
  • Home Healthcare Settings
  • Hospitals
  • Others

Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • UK
  • APAC
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Turkey

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

 

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET SEGMENTATION BY GEOGRAPHY

 

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

 

6 MARKET AT A GLANCE

7 PREMIUM INSIGHTS

7.1 MARKET OVERVIEW

7.1.1 MARKET DYNAMICS

7.1.2 MARKET SEGMENTATION

7.1.3 VENDOR ANALYSIS

7.1.4 RECENT ADVANCES

 

8 INTRODUCTION

8.1 OVERVIEW

8.1.1 RISK FACTORS

8.1.2 DIAGNOSIS OF SLEEP APNEA

8.1.3 TREATMENT FOR SLEEP APNEA

9 MARKET OPPORTUNITIES & TRENDS

9.1 IMPLEMENTATION OF AI IN SLEEP APNEA TREATMENTS

9.2 GROWING DEMAND AND ADVANCES IN HOME SLEEP APNEA TESTS (HSATS)

9.3 GROWING ADOPTION OF TELEMEDICINE, MHEALTH IN SLEEP APNEA TREATMENT

9.4 GROWING POPULARITY OF NON-CPAP DEVICES FOR SLEEP APNEA TREATMENT

 

10 MARKET GROWTH ENABLERS

10.1 IMPROVEMENTS IN SLEEP APNEA DIAGNOSIS

10.2 TECHNOLOGICAL ADVANCES IN CPAP THERAPY

10.3 INCREASING TARGET PATIENT POPULATION

10.4 HIGH GROWTH POTENTIAL FOR UPPER AIRWAY STIMULATION THERAPY (IMPLANT) SYSTEM

 

11 MARKET RESTRAINTS

11.1 PRESENCE OF NUMEROUS UNDIAGNOSED PATIENTS

11.2 HIGH COST OF SLEEP APNEA DEVICES

11.3 AVAILABILITY OF SURGICAL OPTION TO TREAT SLEEP APNEA

11.4 LACK OF PATIENT ADHERENCE TO CPAP DEVICE

 

12 MARKET LANDSCAPE

12.1 MARKET OVERVIEW

12.2 MARKET SIZE & FORECAST

12.2.1 INSIGHTS BY GEOGRAPHY SEGMENTATION

12.2.2 INSIGHTS BY PRODUCT SEGMENTATION

12.2.3 INSIGHTS BY AGE GROUP SEGMENTATION

12.2.4 INSIGHTS BY GENDER SEGMENTATION

12.2.5 INSIGHTS BY END-USER SEGMENTATION

12.3 FIVE FORCES ANALYSIS

12.3.1 THREAT OF NEW ENTRANTS

12.3.2 BARGAINING POWER OF SUPPLIERS

12.3.3 BARGAINING POWER OF BUYERS

12.3.4 THREAT OF SUBSTITUTES

12.3.5 COMPETITIVE RIVALRY

 

13 PRODUCT

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.3 THERAPEUTIC DEVICES

13.3.1 MARKET OVERVIEW

13.3.2 MARKET SIZE & FORECAST

13.3.3 MARKET BY GEOGRAPHY

13.4 FACIAL INTERFACES

13.4.1 MARKET OVERVIEW

13.4.2 MARKET SIZE & FORECAST

13.4.3 MARKET BY GEOGRAPHY

13.5 DIAGNOSTICS DEVICES

13.5.1 MARKET OVERVIEW

13.5.2 MARKET SIZE & FORECAST

13.5.3 MARKET BY GEOGRAPHY

 

14 AGE GROUP

14.1 MARKET SNAPSHOT & GROWTH ENGINE

14.2 MARKET OVERVIEW

14.3 BETWEEN 41 & 60 YEARS

14.3.1 MARKET OVERVIEW

14.3.2 MARKET SIZE & FORECAST

14.3.3 MARKET BY GEOGRAPHY

14.4 61 YEARS & ABOVE

14.4.1 MARKET OVERVIEW

14.4.2 MARKET SIZE & FORECAST

14.4.3 MARKET BY GEOGRAPHY

14.5 BELOW 40 YEARS

14.5.1 MARKET OVERVIEW

14.5.2 MARKET SIZE & FORECAST

14.5.3 MARKET BY GEOGRAPHY

 

15 GENDER

15.1 MARKET SNAPSHOT & GROWTH ENGINE

15.2 MARKET OVERVIEW

15.3 MALES

15.3.1 MARKET OVERVIEW

15.3.2 MARKET SIZE & FORECAST

15.3.3 MARKET BY GEOGRAPHY

15.4 FEMALES

15.4.1 MARKET OVERVIEW

15.4.2 MARKET SIZE & FORECAST

15.4.3 MARKET BY GEOGRAPHY

 

16 END-USER

16.1 MARKET SNAPSHOT & GROWTH ENGINE

16.2 MARKET OVERVIEW

16.3 SLEEP CLINICS/LABS

16.3.1 MARKET OVERVIEW

16.3.2 MARKET SIZE & FORECAST

16.3.3 MARKET BY GEOGRAPHY

16.4 HOME HEALTHCARE SETTINGS

16.4.1 MARKET OVERVIEW

16.4.2 MARKET SIZE & FORECAST

16.4.3 MARKET BY GEOGRAPHY

16.5 HOSPITALS

16.5.1 MARKET OVERVIEW

16.5.2 MARKET SIZE & FORECAST

16.5.3 MARKET BY GEOGRAPHY

16.6 OTHERS

16.6.1 MARKET OVERVIEW

16.6.2 MARKET SIZE & FORECAST

16.6.3 MARKET BY GEOGRAPHY

 

17 GEOGRAPHY

17.1 MARKET SNAPSHOT & GROWTH ENGINE

17.2 GEOGRAPHIC OVERVIEW

 

18 NORTH AMERICA

18.1 MARKET OVERVIEW

18.2 MARKET SIZE & FORECAST

18.2.1 NORTH AMERICA: PRODUCT SEGMENTATION

18.2.2 NORTH AMERICA: AGE GROUP SEGMENTATION

18.2.3 NORTH AMERICA: GENDER SEGMENTATION

18.2.4 NORTH AMERICA: END USER SEGMENTATION

18.3 KEY COUNTRIES

18.3.1 US: MARKET SIZE & FORECAST

18.3.2 CANADA: MARKET SIZE & FORECAST

 

19 EUROPE

19.1 MARKET OVERVIEW

19.2 MARKET SIZE & FORECAST

19.2.1 EUROPE: PRODUCT SEGMENTATION

19.2.2 EUROPE: AGE GROUP SEGMENTATION

19.2.3 EUROPE: GENDER SEGMENTATION

19.2.4 EUROPE: END USER SEGMENTATION

19.3 KEY COUNTRIES

19.3.1 GERMANY: MARKET SIZE & FORECAST

19.3.2 FRANCE: MARKET SIZE & FORECAST

19.3.3 UK: MARKET SIZE & FORECAST

19.3.4 ITALY: MARKET SIZE & FORECAST

19.3.5 SPAIN: MARKET SIZE & FORECAST

 

20 APAC

20.1 MARKET OVERVIEW

20.2 MARKET SIZE & FORECAST

20.2.1 APAC: PRODUCT SEGMENTATION

20.2.2 APAC: AGE GROUP SEGMENTATION

20.2.3 APAC: GENDER SEGMENTATION

20.2.4 APAC: END USER SEGMENTATION

20.3 KEY COUNTRIES

20.3.1 CHINA: MARKET SIZE & FORECAST

20.3.2 JAPAN: MARKET SIZE & FORECAST

20.3.3 INDIA: MARKET SIZE & FORECAST

20.3.4 SOUTH KOREA: MARKET SIZE & FORECAST

20.3.5 AUSTRALIA: MARKET SIZE & FORECAST

 

21 LATIN AMERICA

21.1 MARKET OVERVIEW

21.2 MARKET SIZE & FORECAST

21.2.1 LATIN AMERICA: PRODUCT SEGMENTATION

21.2.2 LATIN AMERICA: AGE GROUP SEGMENTATION

21.2.3 LATIN AMERICA: GENDER SEGMENTATION

21.2.4 LATIN AMERICA: END USER SEGMENTATION

21.3 KEY COUNTRIES

21.3.1 BRAZIL: MARKET SIZE & FORECAST

21.3.2 MEXICO: MARKET SIZE & FORECAST

21.3.3 ARGENTINA: MARKET SIZE & FORECAST

 

22 MIDDLE EAST & AFRICA

22.1 MARKET OVERVIEW

22.2 MARKET SIZE & FORECAST

22.2.1 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION

22.2.2 MIDDLE EAST & AFRICA: AGE GROUP SEGMENTATION

22.2.3 MIDDLE EAST & AFRICA: GENDER SEGMENTATION

22.2.4 MIDDLE EAST & AFRICA: END USER SEGMENTATION

22.3 KEY COUNTRIES

22.3.1 TURKEY: MARKET SIZE & FORECAST

22.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST

22.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST

 

23 COMPETITIVE LANDSCAPE

23.1 COMPETITION OVERVIEW

23.2 MARKET SHARE ANALYSIS

 

24 KEY COMPANY PROFILES

24.1 NIHON KOHDEN CORPORATION

24.1.1 BUSINESS OVERVIEW

24.1.2 NIHON KOHDEN CORPORATION IN SLEEP APNEA MARKET

24.1.3 PRODUCT OFFERINGS

24.1.4 KEY STRATEGIES

24.1.5 KEY STRENGTHS

24.1.6 KEY OPPORTUNITIES

24.2 BMC MEDICAL

24.2.1 BUSINESS OVERVIEW

24.2.2 BMC MEDICAL IN SLEEP APNEA MARKET

24.2.3 PRODUCT OFFERINGS

24.2.4 KEY STRATEGIES

24.2.5 KEY STRENGTHS

24.2.6 KEY OPPORTUNITIES

24.3 DRIVE DEVILBISS HEALTHCARE

24.3.1 BUSINESS OVERVIEW

24.3.2 DRIVE DEVILBISS HEALTHCARE IN SLEEP APNEA MARKET

24.3.3 PRODUCT OFFERINGS

24.3.4 KEY STRATEGIES

24.3.5 KEY STRENGTHS

24.3.6 KEY OPPORTUNITIES

24.4 SOMNOMED

24.4.1 BUSINESS OVERVIEW

24.4.2 SOMNOMED IN SLEEP APNEA MARKET

24.4.3 PRODUCT OFFERINGS

24.4.4 KEY STRATEGIES

24.4.5 KEY STRENGTHS

24.4.6 KEY OPPORTUNITIES

24.5 GLIDEWELL

24.5.1 BUSINESS OVERVIEW

24.5.2 GLIDEWELL IN SLEEP APNEA MARKET

24.5.3 PRODUCT OFFERINGS

24.5.4 KEY STRATEGIES

24.5.5 KEY STRENGTHS

24.5.6 KEY OPPORTUNITIES

24.6 RESMED

24.6.1 BUSINESS OVERVIEW

24.6.2 RESMED IN SLEEP APNEA MARKET

24.6.3 PRODUCT OFFERINGS

24.6.4 KEY STRATEGIES

24.6.5 KEY STRENGTHS

24.6.6 KEY OPPORTUNITIES

24.7 KONINKLIJKE PHILIPS N.V

24.7.1 BUSINESS OVERVIEW

24.7.2 KONINKLIJKE PHILIPS N.V IN SLEEP APNEA MARKET

24.7.3 PRODUCT OFFERINGS

24.7.4 KEY STRATEGIES

24.7.5 KEY STRENGTHS

24.7.6 KEY OPPORTUNITIES

24.8 FISHER & PAYKEL HEALTHCARE

24.8.1 BUSINESS OVERVIEW

24.8.2 FISHER & PAYKEL HEALTHCARE IN SLEEP APNEA MARKET

24.8.3 PRODUCT OFFERINGS

24.8.4 KEY STRATEGIES

24.8.5 KEY STRENGTHS

24.8.6 KEY OPPORTUNITIES

24.9 COMPUMEDICS LIMITED

24.9.1 BUSINESS OVERVIEW

24.9.2 COMPUMEDICS IN SLEEP APNEA MARKET

24.9.3 PRODUCT OFFERINGS

24.9.4 KEY STRATEGIES

24.9.5 KEY STRENGTHS

24.9.6 KEY OPPORTUNITIES

24.10 INSPIRE MEDICAL SYSTEMS

24.10.1 BUSINESS OVERVIEW

24.10.2 INSPIRE MEDICAL SYSTEMS IN SLEEP APNEA MARKET

24.10.3 PRODUCT OFFERINGS

24.10.4 KEY STRATEGIES

24.10.5 KEY STRENGTHS

24.10.6 KEY OPPORTUNITIES

24.11 NATUS MEDICAL

24.11.1 BUSINESS OVERVIEW

24.11.2 NATUS MEDICAL IN SLEEP APNEA MARKET

24.11.3 PRODUCT OFFERINGS

24.11.4 KEY STRATEGIES

24.11.5 KEY STRENGTHS

24.11.6 KEY OPPORTUNITIES

24.12 ITAMAR MEDICAL

24.12.1 BUSINESS OVERVIEW

24.12.2 ITAMAR MEDICAL IN SLEEP APNEA DEVICES MARKET

24.12.3 PRODUCT OFFERINGS

24.12.4 KEY STRATEGIES

24.12.5 KEY STRENGTHS

24.12.6 KEY OPPORTUNITIES

 

25 OTHER PROMINENT VENDORS

25.1 APEX MEDICAL

25.1.1 BUSINESS OVERVIEW

25.1.2 PRODUCT OFFERINGS

25.2 CADWELL INDUSTRIES

25.2.1 BUSINESS OVERVIEW

25.2.2 PRODUCT OFFERINGS

25.3 SOMNOMEDICS

25.3.1 BUSINESS OVERVIEW

25.3.2 PRODUCT OFFERINGS

25.4 CLEVELAND MEDICAL DEVICES

25.4.1 BUSINESS OVERVIEW

25.4.2 PRODUCT OFFERINGS

25.5 PROSOMNUS SLEEP TECHNOLOGIES

25.5.1 BUSINESS OVERVIEW

25.5.2 PRODUCT OFFERINGS

25.6 MEDITAS

25.6.1 BUSINESS OVERVIEW

25.6.2 PRODUCT OFFERINGS

25.7 WHITE DENTAL HEALTHCARE

25.7.1 BUSINESS OVERVIEW

25.7.2 PRODUCT OFFERINGS

25.8 OVENTUS

25.8.1 BUSINESS OVERVIEW

25.8.2 PRODUCT OFFERINGS

25.9 TOMED

25.9.1 BUSINESS OVERVIEW

25.9.2 PRODUCT OFFERINGS

25.10 SIGNIFIER MEDICAL TECHNOLOGIES

25.10.1 BUSINESS OVERVIEW

25.10.2 PRODUCT OFFERINGS

25.11 APNEAMED

25.11.1 BUSINESS OVERVIEW

25.11.2 PRODUCT OFFERINGS

25.12 NYXOAH

25.12.1 BUSINESS OVERVIEW

25.12.2 PRODUCT OFFERINGS

25.13 VIVOS THERAPEUTICS

25.13.1 BUSINESS OVERVIEW

25.13.2 PRODUCT OFFERINGS

25.14 SOMNOWELL

25.14.1 BUSINESS OVERVIEW

25.14.2 PRODUCT OFFERINGS

25.15 REMSLEEP HOLDINGS

25.15.1 BUSINESS OVERVIEW

25.15.2 PRODUCT OFFERINGS

25.16 SIESTA MEDICAL

25.16.1 BUSINESS OVERVIEW

25.16.2 PRODUCT OFFERINGS

25.17 HORIZON PRIME

25.17.1 BUSINESS OVERVIEW

25.17.2 PRODUCT OFFERINGS

25.18 NOX MEDICAL

25.18.1 BUSINESS OVERVIEW

25.18.2 PRODUCT OFFERINGS

25.19 ONERA HEALTH

25.19.1 BUSINESS OVERVIEW

25.19.2 PRODUCT OFFERINGS

25.20 LIVANOVA

25.20.1 BUSINESS OVERVIEW

25.20.2 PRODUCT OFFERINGS

25.21 ZOLL MEDICAL

25.21.1 BUSINESS OVERVIEW

25.21.2 PRODUCT OFFERINGS

25.22 BRAEBON MEDICAL

25.22.1 BUSINESS OVERVIEW

25.22.2 PRODUCT OFFERINGS

25.23 INVACARE

25.23.1 BUSINESS OVERVIEW

25.23.2 PRODUCT OFFERINGS

25.24 BREAS MEDICAL

25.24.1 BUSINESS OVERVIEW

25.24.2 PRODUCT OFFERINGS

 

26 REPORT SUMMARY

26.1 KEY TAKEAWAYS

26.2 STRATEGIC RECOMMENDATIONS.

 

27 QUANTITATIVE SUMMARY

27.1 MARKET BY PRODUCT

27.1.1 NORTH AMERICA: PRODUCT SEGMENTATION

27.1.2 EUROPE: PRODUCT SEGMENTATION

27.1.3 APAC: PRODUCT SEGMENTATION

27.1.4 LATIN AMERICA: PRODUCT SEGMENTATION

27.1.5 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION

27.2 MARKET BY AGE GROUP

27.2.1 NORTH AMERICA: AGE GROUP SEGMENTATION

27.2.2 EUROPE: AGE GROUP SEGMENTATION

27.2.3 APAC: AGE GROUP SEGMENTATION

27.2.4 LATIN AMERICA: AGE GROUP SEGMENTATION

27.2.5 MIDDLE EAST & AFRICA: AGE GROUP SEGMENTATION

27.3 MARKET BY GENDER

27.3.1 NORTH AMERICA: GENDER SEGMENTATION

27.3.2 EUROPE: GENDER SEGMENTATION

27.3.3 APAC: GENDER SEGMENTATION

27.3.4 LATIN AMERICA: GENDER SEGMENTATION

27.3.5 MIDDLE EAST & AFRICA: GENDER SEGMENTATION

27.4 MARKET BY END USER

27.4.1 NORTH AMERICA: END USER SEGMENTATION

27.4.2 EUROPE: END USER SEGMENTATION

27.4.3 APAC: END USER SEGMENTATION

27.4.4 LATIN AMERICA: END USER SEGMENTATION

27.4.5 MIDDLE EAST & AFRICA: END USER SEGMENTATION

27.5 MARKET BY GEOGRAPHY

27.5.1 THERAPEUTIC DEVICES: GEOGRAPHY SEGMENTATION

27.5.2 FACIAL INTERFACES: GEOGRAPHY SEGMENTATION

27.5.3 DIAGNOSTICS DEVICE: GEOGRAPHY SEGMENTATION

27.5.4 BETWEEN 41 & 60 YEARS: GEOGRAPHY SEGMENTATION

27.5.5 61 YEARS & ABOVE: GEOGRAPHY SEGMENTATION

27.5.6 BELOW 40 YEARS: GEOGRAPHY SEGMENTATION

27.5.7 MALES: GEOGRAPHY SEGMENTATION

27.5.8 FEMALES: GEOGRAPHY SEGMENTATION

27.5.9 SLEEP CLINICS/LABS: GEOGRAPHY SEGMENTATION

27.5.10 HOME HEALTHCARE SETTINGS: GEOGRAPHY SEGMENTATION

27.5.11 HOSPITALS: GEOGRAPHY SEGMENTATION

27.5.12 OTHERS: GEOGRAPHY SEGMENTATION

 

28 APPENDIX

28.1 ABBREVIATIONS

 

LIST OF EXHIBITS

EXHIBIT 1 SEGMENTATION OF GLOBAL SLEEP APNEA DEVICES MARKET

EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021

EXHIBIT 3 GLOBAL SLEEP APNEA DEVICES MARKET 2021 & 2027 ($ MILLION)

EXHIBIT 4 GLOBAL SLEEP APNEA DEVICES MARKET SEGMENTATION

EXHIBIT 5 SYMPTOMS OF OSA

EXHIBIT 6 RISK FACTORS FOR SLEEP APNEA

EXHIBIT 7 IMPACT OF IMPLEMENTATION OF AI IN SLEEP APNEA TREATMENTS

EXHIBIT 8 IMPACT OF GROWING DEMAND AND ADVANCES IN HSATS

EXHIBIT 9 THE ADVANTAGES OF TAKING A HOME SLEEP APNEA TEST

EXHIBIT 10 IMPACT OF GROWING ADOPTION OF TELEMEDICINE, MHEALTH IN SLEEP APNEA TREATMENT

EXHIBIT 11 ADVANTAGES OF TELEMEDICINE IN THE MANAGEMENT OF SLEEP APNEA

EXHIBIT 12 TELEHEALTH CONSULTATION SCHEDULED AND COMPLETED BY EMERGING NON-CPAP VENDOR

EXHIBIT 13 IMPACT OF GROWING POPULARITY OF NON-CPAP DEVICES FOR SLEEP APNEA TREATMENT

EXHIBIT 14 PATIENTS STRUGGLE WITH CONVENTIONAL TREATMENT WAYS

EXHIBIT 15 IMPACT OF IMPROVEMENTS IN SLEEP APNEA DIAGNOSIS

EXHIBIT 16 ROLE OF SENSORS & REMOTE MONITORING IN SLEEP APNEA DIAGNOSIS

EXHIBIT 17 IMPACT OF TECHNOLOGICAL ADVANCES IN CPAP THERAPY

EXHIBIT 18 IMPACT OF INCREASING TARGET PATIENT POPULATION

EXHIBIT 19 TYPE 2 DIABETES STATISTICS (MILLION)

EXHIBIT 20 SIGNIFICANT COMORBIDITIES OF CARDIOVASCULAR DISEASES FOR SLEEP APNEA

EXHIBIT 21 IMPACT OF HIGH GROWTH POTENTIAL FOR UPPER AIRWAY STIMULATION THERAPY (IMPLANT) SYSTEM

EXHIBIT 22 IMPACT OF PRESENCE ON NUMEROUS UNDIAGNOSED PATIENTS

EXHIBIT 23 IMPACT OF HIGH COST OF SLEEP APNEA DEVICES

EXHIBIT 24 IMPACT OF AVAILABILITY OF SURGICAL OPTION TO TREAT SLEEP APNEA

EXHIBIT 25 IMPACT OF LACK OF PATIENT ADHERENCE TO CPAP DEVICE

EXHIBIT 26 GLOBAL SLEEP APNEA DEVICES MARKET 2021–2027 ($ MILLION)

EXHIBIT 27 GLOBAL SLEEP APNEA DEVICES MARKET BY GEOGRAPHY: MARKET SHARE 2021 & 2027

EXHIBIT 28 GLOBAL SLEEP APNEA DEVICES MARKET BY GEOGRAPHY: MARKET SHARE 2021 & 2027

EXHIBIT 29 GLOBAL SLEEP APNEA DEVICES MARKET BY AGE GROUP: MARKET SHARE 2021 & 2027

EXHIBIT 30 GLOBAL SLEEP APNEA DEVICES MARKET BY GENDER: MARKET SHARE 2021 & 2027

EXHIBIT 31 GLOBAL SLEEP APNEA DEVICES MARKET BY END-USER: MARKET SHARE 2021 & 2027

EXHIBIT 32 FIVE FORCES ANALYSIS 2021

EXHIBIT 33 INCREMENTAL GROWTH BY PRODUCT SEGMENT 2021 & 2027

EXHIBIT 34 GLOBAL SLEEP APNEA DEVICES MARKET BY PRODUCT

EXHIBIT 35 GLOBAL SLEEP APNEA DEVICES MARKET BY PRODUCT: INCREMENTAL GROWTH

EXHIBIT 36 GLOBAL SLEEP APNEA DEVICE TYPE

EXHIBIT 37 GLOBAL SLEEP APNEA DEVICES MARKET BY PRODUCT: ABSOLUTE GROWTH

EXHIBIT 38 GLOBAL THERAPEUTIC SLEEP APNEA DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 39 SILENT FEATURES OF APAP DEVICE

EXHIBIT 40 TYPES OF MADS

EXHIBIT 41 GLOBAL THERAPEUTIC SLEEP APNEA DEVICES MARKET 2021–2027 ($ MILLION)

EXHIBIT 42 CPAP MASK DESIGN & STRUCTURE

EXHIBIT 43 GLOBAL SLEEP APNEA DEVICES MARKET BY FACIAL INTERFACES: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 44 GLOBAL SLEEP APNEA DEVICES MARKET BY FACIAL INTERFACES 2021–2027 ($ MILLION)

EXHIBIT 45 GLOBAL DIAGNOSTICS SLEEP APNEA DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 46 GLOBAL DIAGNOSTICS SLEEP APNEA DEVICES MARKET 2021–2027 ($ MILLION)

EXHIBIT 47 INCREMENTAL GROWTH BY AGE GROUP 2021 & 2027

EXHIBIT 48 GLOBAL SLEEP APNEA DEVICES MARKET BY AGE GROUP

EXHIBIT 49 GLOBAL SLEEP APNEA DEVICES MARKET BY AGE GROUP: INCREMENTAL GROWTH

EXHIBIT 50 GLOBAL SLEEP APNEA DEVICES MARKET BY AGE GROUP: ABSOLUTE GROWTH

EXHIBIT 51 GLOBAL SLEEP APNEA DEVICES MARKET BY BETWEEN 41 & 60 YEARS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 52 GLOBAL SLEEP APNEA DEVICES MARKET BY BETWEEN 41 & 60 YEARS 2021–2027 ($ MILLION)

EXHIBIT 53 GLOBAL SLEEP APNEA DEVICES MARKET BY 61 YEARS & ABOVE: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 54 GLOBAL SLEEP APNEA DEVICES MARKET BY 61 YEARS & ABOVE 2021–2027 ($ MILLION)

EXHIBIT 55 COMMON CAUSE OF OSA IN YOUNG ADULTS 18-40 YEARS OLD

EXHIBIT 56 GLOBAL SLEEP APNEA DEVICES MARKET BY BELOW 40 YEARS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 57 GLOBAL SLEEP APNEA DEVICES MARKET BY BELOW 40 YEARS 2021–2027 ($ MILLION)

EXHIBIT 58 INCREMENTAL GROWTH BY GENDER 2021 & 2027

EXHIBIT 59 GLOBAL SLEEP APNEA DEVICES MARKET BY GENDER

EXHIBIT 60 GLOBAL SLEEP APNEA DEVICES MARKET BY GENDER: INCREMENTAL GROWTH

EXHIBIT 61 GLOBAL SLEEP APNEA DEVICES MARKET BY GENDER: ABSOLUTE GROWTH

EXHIBIT 62 GLOBAL SLEEP APNEA DEVICES MARKET BY MALES: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 63 GLOBAL SLEEP APNEA DEVICES MARKET BY MALES 2021–2027 ($ MILLION)

EXHIBIT 64 GLOBAL SLEEP APNEA DEVICES MARKET BY FEMALES: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 65 GLOBAL SLEEP APNEA DEVICES MARKET BY FEMALES 2021–2027 ($ MILLION)

EXHIBIT 66 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 67 GLOBAL SLEEP APNEA DEVICES MARKET BY END-USER

EXHIBIT 68 GLOBAL SLEEP APNEA DEVICES MARKET BY END-USER: INCREMENTAL GROWTH

EXHIBIT 69 GLOBAL SLEEP APNEA DEVICES MARKET BY END-USER: ABSOLUTE GROWTH

EXHIBIT 70 GLOBAL SLEEP APNEA DEVICES MARKET BY SLEEP CLINICS/LABS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 71 GLOBAL SLEEP APNEA DEVICES MARKET BY SLEEP CLINICS/LABS 2021–2027 ($ MILLION)

EXHIBIT 72 GLOBAL SLEEP APNEA DEVICES MARKET BY HOME HEALTHCARE SETTINGS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 73 GLOBAL SLEEP APNEA DEVICES MARKET BY HOME HEALTHCARE SETTINGS 2021–2027 ($ MILLION)

EXHIBIT 74 GLOBAL SLEEP APNEA DEVICES MARKET BY HOME HEALTHCARE SETTINGS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 75 GLOBAL SLEEP APNEA DEVICES MARKET BY HOSPITALS 2021–2027 ($ MILLION)

EXHIBIT 76 GLOBAL SLEEP APNEA DEVICES MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 77 GLOBAL SLEEP APNEA DEVICES MARKET BY OTHER END-USERS 2021–2027 ($ MILLION)

EXHIBIT 78 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 79 GLOBAL SLEEP APNEA DEVICES MARKET BY GEOGRAPHY

EXHIBIT 80 GLOBAL SLEEP APNEA DEVICES MARKET BY GEOGRAPHY: KEY COUNTRIES 2021

EXHIBIT 81 GLOBAL SLEEP APNEA DEVICES MARKET BY GEOGRAPHY: INCREMENTAL GROWTH

EXHIBIT 82 GLOBAL SLEEP APNEA DEVICES MARKET BY GEOGRAPHY: ABSOLUTE GROWTH

EXHIBIT 83 SLEEP DEPRIVATION STATISTICS OF THE U.S.

EXHIBIT 84 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA: KEY COUNTRIES

EXHIBIT 85 GLOBAL SLEEP APNEA DEVICES MARKET BY NORTH AMERICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 86 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA 2021–2027 ($ MILLION)

EXHIBIT 87 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027

EXHIBIT 88 PREVALENCE & TREATMENT RATE IN US

EXHIBIT 89 US WORK STRESS STATISTICS

EXHIBIT 90 SLEEP APNEA DEVICES MARKET IN US 2021–2027 ($ MILLION)

EXHIBIT 91 CANADIAN HEALTH MEASURES SURVEY (CHMS) 2016-2017

EXHIBIT 92 PREVALENCE OF SLEEP APNEA AMONG ADULTS AGED 18-79 YEARS

EXHIBIT 93 SLEEP APNEA DEVICES MARKET IN CANADA 2021–2027 ($ MILLION)

EXHIBIT 94 SLEEP APNEA DEVICES MARKET IN EUROPE: KEY COUNTRIES

EXHIBIT 95 PREVALENCE OF OSA IN EUROPEAN COUNTRIES IN 2018

EXHIBIT 96 GLOBAL SLEEP APNEA DEVICES MARKET BY EUROPE: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 97 SLEEP APNEA DEVICES MARKET IN EUROPE 2021–2027 ($ MILLION)

EXHIBIT 98 INCREMENTAL GROWTH IN EUROPE 2021 & 2027

EXHIBIT 99 SLEEP APNEA DEVICES MARKET IN GERMANY 2021–2027 ($ MILLION)

EXHIBIT 100 PREVALENCE OF OBESITY AMONG YOUNG PEOPLE BETWEEN 8 AND 17 YEARS

EXHIBIT 101 PREVALENCE OF TREATMENT FOR OSA WITH CPAP

EXHIBIT 102 SLEEP APNEA DEVICES MARKET IN FRANCE 2021–2027 ($ MILLION)

EXHIBIT 103 OSA AND ITS TREATMENT STATISTICS OF UK

EXHIBIT 104 SLEEP APNEA DEVICES MARKET IN UK 2021–2027 ($ MILLION)

EXHIBIT 105 SLEEP APNEA DEVICES MARKET IN ITALY 2021–2027 ($ MILLION)

EXHIBIT 106 SLEEP APNEA DEVICES MARKET IN SPAIN 2021–2027 ($ MILLION)

EXHIBIT 107 SLEEP APNEA DEVICES MARKET IN APAC: KEY COUNTRIES

EXHIBIT 108 SLEEP APNEA DEVICES MARKET IN APAC: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 109 LIST OF THE LEADING SLEEP APNEA DEVICE VENDOR IN APAC

EXHIBIT 110 SLEEP APNEA DEVICE MARKET IN APAC 2021–2027 ($ MILLION)

EXHIBIT 111 INCREMENTAL GROWTH IN APAC 2021 & 2027

EXHIBIT 112 SLEEP APNEA DEVICE MARKET IN CHINA 2021–2027 ($ MILLION)

EXHIBIT 113 SLEEP APNEA DEVICE MARKET IN JAPAN 2021–2027 ($ MILLION)

EXHIBIT 114 SLEEP APNEA DEVICES MARKET IN INDIA 2021–2027 ($ MILLION)

EXHIBIT 115 SLEEP APNEA DEVICE MARKET IN SOUTH KOREA 2021–2027 ($ MILLION)

EXHIBIT 116 SLEEP APNEA STATISTICS IN AUSTRALIA

EXHIBIT 117 SLEEP APNEA DEVICE MARKET IN AUSTRALIA 2021–2027 ($ MILLION)

EXHIBIT 118 SLEEP APNEA DEVICES MARKET IN LATIN AMERICA: KEY COUNTRIES

EXHIBIT 119 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA 2021–2027 ($ MILLION)

EXHIBIT 120 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027

EXHIBIT 121 OSA STATISTICS IN BRAZIL 2016

EXHIBIT 122 OVERWEIGHT & OBESITY STATISTICS BY NATIONAL HEALTH SURVEY 2019

EXHIBIT 123 SLEEP APNEA DEVICE MARKET IN BRAZIL 2021–2027 ($ MILLION)

EXHIBIT 124 SLEEP APNEA DEVICES MARKET IN MEXICO 2021–2027 ($ MILLION)

EXHIBIT 125 SLEEP APNEA DEVICE MARKET IN ARGENTINA 2021–2027 ($ MILLION)

EXHIBIT 126 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA: KEY COUNTRIES

EXHIBIT 127 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 128 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA 2021–2027 ($ MILLION)

EXHIBIT 129 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027

EXHIBIT 130 SLEEP APNEA DEVICE MARKET IN TURKEY 2021–2027 ($ MILLION)

EXHIBIT 131 SLEEP APNEA DEVICE MARKET IN SAUDI ARABIA 2021–2027 ($ MILLION)

EXHIBIT 132 SLEEP APNEA DEVICE MARKET IN SOUTH AFRICA 2021–2027 ($ MILLION)

EXHIBIT 133 GLOBAL SLEEP APNEA DEVICES MARKET: KEY VENDORS CAPABILITIES & EXPERTISE ASSESSMENT

EXHIBIT 134 GLOBAL SLEEP APNEA DEVICES MARKET: KEY VENDORS CAPABILITIES & EXPERTISE ASSESSMENT

EXHIBIT 135 GLOBAL SLEEP APNEA DEVICES MARKET: KEY VENDORS MARKET DOMINANCE ANALYSIS

EXHIBIT 136 GLOBAL SLEEP APNEA DEVICES MARKET: KEY VENDORS MARKET DOMINANCE ANALYSIS

EXHIBIT 137 NIHON KOHDEN CORPORATION: TOTAL REVENUE 2019-2021 ($ MILLION)

EXHIBIT 138 NIHON KOHDEN CORPORATION: REVENUE BY SEGMENT 2021 (%)

EXHIBIT 139 NIHON KOHDEN CORPORATION: REVENUE BY SEGMENT 2021 (% SHARE)

EXHIBIT 140 SOMNOMED: TOTAL REVENUE 2019-2021 ($ MILLION)

EXHIBIT 141 SOMNOMED: REVENUE BY GEOGRAPHY SEGMENT 2021 (%)

EXHIBIT 142 RESMED: TOTAL REVENUE 2020-2022 ($ MILLION)

EXHIBIT 143 RESMED: R&D EXPENSE 2020-2022 ($ MILLION)

EXHIBIT 144 RESMED: TOTAL REVENUE SHARE BY SEGMENT 2022 (%)

EXHIBIT 145 RESMED: REVENUE BY GEOGRAPHY 2022 (%)

EXHIBIT 146 KONINKLIJKE PHILIPS N.V: TOTAL REVENUE 2019-2021 ($ BILLION)

EXHIBIT 147 KONINKLIJKE PHILIPS N.V: R&D EXPENDITURE 2019-2021 ($ MILLION)

EXHIBIT 148 KONINKLIJKE PHILIPS N.V: REVENUE BY BUSINESS SEGMENTS 2021 (%)

EXHIBIT 149 FISHER & PAYKEL HEALTHCARE: TOTAL REVENUE 2020-2022 ($ MILLION)

EXHIBIT 150 FISHER & PAYKEL HEALTHCARE: R&D EXPENDITURE 2020-2022 ($ MILLION)

EXHIBIT 151 FISHER & PAYKEL HEALTHCARE: REVENUE SHARE BY SEGMENT 2022 (%)

EXHIBIT 152 FISHER & PAYKEL HEALTHCARE: REVENUE SHARE BY GEOGRAPHY 2022 (%)

EXHIBIT 153 COMPUMEDICS: TOTAL REVENUE 2020-2022 ($ MILLION)

EXHIBIT 154 COMPUMEDICS: REVENUE SHARE BY GEOGRAPHY 2022 (%)

EXHIBIT 155 INSPIRE MEDICAL SYSTEMS: TOTAL REVENUE 2019-2021 ($ MILLION)

EXHIBIT 156 INSPIRE MEDICAL SYSTEMS: R&D EXPENDITURE 2019-2021 ($ MILLION)

EXHIBIT 157 INSPIRE MEDICAL SYSTEMS: REVENUE SHARE BY GEOGRAPHY 2021 (%)

 

LIST OF TABLES

TABLE 1 KEY CAVEATS

TABLE 2 CURRENCY CONVERSION 2015−2021

TABLE 3 POPULAR AVAILABLE CPAP DEVICES

TABLE 4 GLOBAL THERAPEUTIC SLEEP APNEA DEVICES MARKET 2021−2027 ($ MILLION)

TABLE 5 GLOBAL THERAPEUTIC SLEEP APNEA DEVICES MARKET 2021−2027 (%)

TABLE 6 GLOBAL SLEEP APNEA DEVICES MARKET BY FACIAL INTERFACES 2021−2027 ($ MILLION)

TABLE 7 GLOBAL SLEEP APNEA DEVICES MARKET BY FACIAL INTERFACES 2021−2027 (%)

TABLE 8 GLOBAL DIAGNOSTICS SLEEP APNEA DEVICES MARKET 2021−2027 ($ MILLION)

TABLE 9 GLOBAL DIAGNOSTICS SLEEP APNEA DEVICES MARKET 2021−2027 (%)

TABLE 10 GLOBAL SLEEP APNEA DEVICES MARKET BY BETWEEN 41 & 60 YEARS 2021−2027 ($ MILLION)

TABLE 11 GLOBAL SLEEP APNEA DEVICES MARKET BY BETWEEN 41 & 60 YEARS 2021−2027 (%)

TABLE 12 GLOBAL SLEEP APNEA DEVICES MARKET BY 61 YEARS & ABOVE 2021−2027 ($ MILLION)

TABLE 13 GLOBAL SLEEP APNEA DEVICES MARKET BY 61 YEARS & ABOVE 2021−2027 (%)

TABLE 14 GLOBAL SLEEP APNEA DEVICES MARKET BY BELOW 40 YEARS 2021−2027 ($ MILLION)

TABLE 15 GLOBAL SLEEP APNEA DEVICES MARKET BY BELOW 40 YEARS 2021−2027 (%)

TABLE 16 SLEEP DISORDERS AND SYMPTOMS STATISTICS OF THE NORTHWEST ADELAIDE HEALTH STUDY (NWAHS) PARTICIPANTS

TABLE 17 GLOBAL SLEEP APNEA DEVICES MARKET BY MALES 2021−2027 ($ MILLION)

TABLE 18 GLOBAL SLEEP APNEA DEVICES MARKET BY MALES 2021−2027 (%)

TABLE 19 GLOBAL SLEEP APNEA DEVICES MARKET BY FEMALES 2021−2027 ($ MILLION)

TABLE 20 GLOBAL SLEEP APNEA DEVICES MARKET BY FEMALES 2021−2027 (%)

TABLE 21 GLOBAL SLEEP APNEA DEVICES MARKET BY SLEEP CLINICS/LABS 2021−2027 ($ MILLION)

TABLE 22 GLOBAL SLEEP APNEA DEVICES MARKET BY SLEEP CLINICS/LABS 2021−2027 (%)

TABLE 23 GLOBAL SLEEP APNEA DEVICES MARKET BY HOME HEALTHCARE SETTINGS 2021−2027 ($ MILLION)

TABLE 24 GLOBAL SLEEP APNEA DEVICES MARKET BY HOME HEALTHCARE SETTINGS 2021−2027 (%)

TABLE 25 GLOBAL SLEEP APNEA DEVICES MARKET BY HOSPITALS 2021−2027 ($ MILLION)

TABLE 26 GLOBAL SLEEP APNEA DEVICES MARKET BY HOSPITALS 2021−2027 (%)

TABLE 27 GLOBAL SLEEP APNEA DEVICES MARKET BY OTHER END-USERS 2021−2027 ($ MILLION)

TABLE 28 GLOBAL SLEEP APNEA DEVICES MARKET BY OTHER END-USERS 2021−2027 (%)

TABLE 29 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA BY PRODUCT 2021−2027 ($ MILLION)

TABLE 30 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA BY PRODUCT 2021−2027 (%)

TABLE 31 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA BY AGE GROUP 2021−2027 ($ MILLION)

TABLE 32 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA BY AGE GROUP 2021−2027 (%)

TABLE 33 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA BY GENDER 2021−2027 ($ MILLION)

TABLE 34 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA BY GENDER 2021−2027 (%)

TABLE 35 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA BY END USER 2021−2027 ($ MILLION)

TABLE 36 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA BY END USER 2021−2027 (%)

TABLE 37 SLEEP APNEA DEVICES MARKET IN EUROPE BY PRODUCT 2021−2027 ($ MILLION)

TABLE 38 SLEEP APNEA DEVICES MARKET IN EUROPE BY PRODUCT 2021−2027 (%)

TABLE 39 SLEEP APNEA DEVICES MARKET IN EUROPE BY AGE GROUP 2021−2027 ($ MILLION)

TABLE 40 SLEEP APNEA DEVICES MARKET IN EUROPE BY 2021−2027 (%)

TABLE 41 SLEEP APNEA DEVICES MARKET IN EUROPE BY GENDER 2021−2027 ($ MILLION)

TABLE 42 SLEEP APNEA DEVICES MARKET IN EUROPE BY GENDER 2021−2027 (%)

TABLE 43 SLEEP APNEA DEVICES MARKET IN EUROPE BY END USER 2021−2027 ($ MILLION)

TABLE 44 SLEEP APNEA DEVICES MARKET IN EUROPE BY END USER 2021−2027 (%)

TABLE 45 SLEEP APNEA DEVICE MARKET IN APAC BY PRODUCT 2021−2027 ($ MILLION)

TABLE 46 SLEEP APNEA DEVICE MARKET IN APAC BY PRODUCT 2021−2027 (%)

TABLE 47 SLEEP APNEA DEVICE MARKET IN APAC BY AGE GROUP 2021−2027 ($ MILLION)

TABLE 48 SLEEP APNEA DEVICE MARKET IN APAC BY AGE GROUP 2021−2027 (%)

TABLE 49 SLEEP APNEA DEVICE MARKET IN APAC BY GENDER 2021−2027 ($ MILLION)

TABLE 50 SLEEP APNEA DEVICE MARKET IN APAC BY GENDER 2021−2027 (%)

TABLE 51 SLEEP APNEA DEVICE MARKET IN APAC BY END USER 2021−2027 ($ MILLION)

TABLE 52 SLEEP APNEA DEVICE MARKET IN APAC BY END USER 2021−2027 (%)

TABLE 53 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA BY PRODUCT 2021−2027 ($ MILLION)

TABLE 54 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA BY PRODUCT 2021−2027 (%)

TABLE 55 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA BY AGE GROUP 2021−2027 ($ MILLION)

TABLE 56 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA BY 2021−2027 (%)

TABLE 57 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA BY GENDER 2021−2027 ($ MILLION)

TABLE 58 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA BY GENDER 2021−2027 (%)

TABLE 59 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA BY END USER 2021−2027 ($ MILLION)

TABLE 60 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA BY END USER 2021−2027 (%)

TABLE 61 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA BY PRODUCT 2021−2027 ($ MILLION)

TABLE 62 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA BY PRODUCT 2021−2027 (%)

TABLE 63 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA BY AGE GROUP 2021−2027 ($ MILLION)

TABLE 64 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA BY 2021−2027 (%)

TABLE 65 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA BY GENDER 2021−2027 ($ MILLION)

TABLE 66 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA BY GENDER 2021−2027 (%)

TABLE 67 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA BY END USER 2021−2027 ($ MILLION)

TABLE 68 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA BY END USER 2021−2027 (%)

TABLE 69 LEADING VENDORS BASED ON SLEEP APNEA PRODUCT PORTFOLIO

TABLE 70 NIHON KOHDEN CORPORATION: MAJOR PRODUCT OFFERINGS

TABLE 71 BMC MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 72 DRIVE DEVILBISS HEALTHCARE: MAJOR PRODUCT OFFERINGS

TABLE 73 SOMNOMED: MAJOR PRODUCT OFFERINGS

TABLE 74 GLIDEWELL: MAJOR PRODUCT OFFERINGS

TABLE 75 RESMED: MAJOR PRODUCT OFFERINGS

TABLE 76 KONINKLIJKE PHILIPS N.V: MAJOR PRODUCT OFFERINGS

TABLE 77 FISHER & PAYKEL HEALTHCARE: MAJOR PRODUCT OFFERINGS

TABLE 78 COMPUMEDICS: MAJOR PRODUCT OFFERINGS

TABLE 79 INSPIRE MEDICAL SYSTEMS: MAJOR PRODUCT OFFERINGS

TABLE 80 NATUS MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 81 ITAMAR MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 82 APEX MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 83 CADWELL INDUSTRIES: MAJOR PRODUCT OFFERINGS

TABLE 84 SOMNOMEDICS: MAJOR PRODUCT OFFERINGS

TABLE 85 CLEVELAND MEDICAL DEVICES: MAJOR PRODUCT OFFERINGS

TABLE 86 PROSOMNUS SLEEP TECHNOLOGIES: MAJOR PRODUCT OFFERINGS

TABLE 87 MEDITAS: MAJOR PRODUCT OFFERINGS

TABLE 88 WHITE DENTAL HEALTHCARE: MAJOR PRODUCT OFFERINGS

TABLE 89 OVENTUS: MAJOR PRODUCT OFFERINGS

TABLE 90 TOMED: MAJOR PRODUCT OFFERINGS

TABLE 91 SIGNIFIER MEDICAL TECHNOLOGIES: MAJOR PRODUCT OFFERINGS

TABLE 92 APNEAMED: MAJOR PRODUCT OFFERINGS

TABLE 93 NYXOAH: MAJOR PRODUCT OFFERINGS

TABLE 94 VIVOS THERAPEUTICS: MAJOR PRODUCT OFFERINGS

TABLE 95 SOMNOWELL: MAJOR PRODUCT OFFERINGS

TABLE 96 REMSLEEP HOLDINGS: MAJOR PRODUCT OFFERINGS

TABLE 97 SIESTA MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 98 HORIZON PRIME: MAJOR PRODUCT OFFERINGS

TABLE 99 NOX MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 100 ONERA HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 101 LIVANOVA: MAJOR PRODUCT OFFERINGS

TABLE 102 ZOLL MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 103 BRAEBON MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 104 INVACARE: MAJOR PRODUCT OFFERINGS

TABLE 105 BREAS MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 106 GLOBAL SLEEP APNEA DEVICES MARKET BY PRODUCT 2021−2027 ($ MILLION)

TABLE 107 GLOBAL SLEEP APNEA DEVICES MARKET BY PRODUCT 2021−2027 (%)

TABLE 108 NORTH AMERICA SLEEP APNEA DEVICES MARKET BY PRODUCT 2021−2027 ($ MILLION)

TABLE 109 NORTH AMERICA SLEEP APNEA DEVICES MARKET BY PRODUCT 2021−2027 (%)

TABLE 110 EUROPE SLEEP APNEA DEVICES MARKET BY PRODUCT 2021−2027 ($ MILLION)

TABLE 111 EUROPE SLEEP APNEA DEVICES MARKET BY PRODUCT 2021−2027 (%)

TABLE 112 APAC SLEEP APNEA DEVICES MARKET BY PRODUCT 2021−2027 ($ MILLION)

TABLE 113 APAC SLEEP APNEA DEVICES MARKET BY PRODUCT 2021−2027 (%)

TABLE 114 LATIN AMERICA SLEEP APNEA DEVICES MARKET BY PRODUCT 2021−2027 ($ MILLION)

TABLE 115 LATIN AMERICA SLEEP APNEA DEVICES MARKET BY PRODUCT 2021−2027 (%)

TABLE 116 MIDDLE EAST & AFRICA SLEEP APNEA DEVICES MARKET BY PRODUCT 2021−2027 ($ MILLION)

TABLE 117 MIDDLE EAST & AFRICA SLEEP APNEA DEVICES MARKET BY PRODUCT 2021−2027 (%)

TABLE 118 GLOBAL SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021−2027 ($ MILLION)

TABLE 119 GLOBAL SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021−2027 (%)

TABLE 120 NORTH AMERICA SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021−2027 ($ MILLION)

TABLE 121 NORTH AMERICA SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021−2027 (%)

TABLE 122 EUROPE SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021−2027 ($ MILLION)

TABLE 123 EUROPE SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021−2027 (%)

TABLE 124 APAC SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021−2027 ($ MILLION)

TABLE 125 APAC SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021−2027 (%)

TABLE 126 LATIN AMERICA SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021−2027 ($ MILLION)

TABLE 127 LATIN AMERICA SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021−2027 (%)

TABLE 128 MIDDLE EAST & AFRICA SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021−2027 ($ MILLION)

TABLE 129 MIDDLE EAST & AFRICA SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021−2027 (%)

TABLE 130 GLOBAL SLEEP APNEA DEVICES MARKET BY GENDER 2021−2027 ($ MILLION)

TABLE 131 GLOBAL SLEEP APNEA DEVICES MARKET BY GENDER 2021−2027 (%)

TABLE 132 NORTH AMERICA SLEEP APNEA DEVICES MARKET BY GENDER 2021−2027 ($ MILLION)

TABLE 133 NORTH AMERICA SLEEP APNEA DEVICES MARKET BY GENDER 2021−2027 (%)

TABLE 134 EUROPE SLEEP APNEA DEVICES MARKET BY GENDER 2021−2027 ($ MILLION)

TABLE 135 EUROPE SLEEP APNEA DEVICES MARKET BY GENDER 2021−2027 (%)

TABLE 136 APAC SLEEP APNEA DEVICES MARKET BY GENDER 2021−2027 ($ MILLION)

TABLE 137 APAC SLEEP APNEA DEVICES MARKET BY GENDER 2021−2027 (%)

TABLE 138 LATIN AMERICA SLEEP APNEA DEVICES MARKET BY GENDER 2021−2027 ($ MILLION)

TABLE 139 LATIN AMERICA SLEEP APNEA DEVICES MARKET BY GENDER 2021−2027 (%)

TABLE 140 MIDDLE EAST & AFRICA SLEEP APNEA DEVICES MARKET BY GENDER 2021−2027 ($ MILLION)

TABLE 141 MIDDLE EAST & AFRICA SLEEP APNEA DEVICES MARKET BY GENDER 2021−2027 (%)

TABLE 142 GLOBAL SLEEP APNEA DEVICES MARKET BY END-USER 2021−2027 ($ MILLION)

TABLE 143 GLOBAL SLEEP APNEA DEVICES MARKET BY END-USER 2021−2027 (%)

TABLE 144 NORTH AMERICA SLEEP APNEA DEVICES MARKET BY END-USER 2021−2027 ($ MILLION)

TABLE 145 NORTH AMERICA SLEEP APNEA DEVICES MARKET BY END-USER 2021−2027 (%)

TABLE 146 EUROPE SLEEP APNEA DEVICES MARKET BY END-USER 2021−2027 ($ MILLION)

TABLE 147 EUROPE SLEEP APNEA DEVICES MARKET BY END-USER 2021−2027 (%)

TABLE 148 APAC SLEEP APNEA DEVICES MARKET BY END-USER 2021−2027 ($ MILLION)

TABLE 149 APAC SLEEP APNEA DEVICES MARKET BY END-USER 2021−2027 (%)

TABLE 150 LATIN AMERICA SLEEP APNEA DEVICES MARKET BY END-USER 2021−2027 ($ MILLION)

TABLE 151 LATIN AMERICA SLEEP APNEA DEVICES MARKET BY END-USER 2021−2027 (%)

TABLE 152 MIDDLE EAST & AFRICA SLEEP APNEA DEVICES MARKET BY END-USER 2021−2027 ($ MILLION)

TABLE 153 MIDDLE EAST & AFRICA SLEEP APNEA DEVICES MARKET BY END-USER 2021−2027 (%)

TABLE 154 GLOBAL SLEEP APNEA DEVICES MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)

TABLE 155 GLOBAL SLEEP APNEA DEVICES MARKET BY GEOGRAPHY 2021−2027 (%)

TABLE 156 GLOBAL THERAPEUTIC SLEEP APNEA DEVICES MARKET 2021−2027 ($ MILLION)

TABLE 157 GLOBAL THERAPEUTIC SLEEP APNEA DEVICES MARKET 2021−2027 (%)

TABLE 158 GLOBAL SLEEP APNEA DEVICES MARKET BY FACIAL INTERFACES 2021−2027 ($ MILLION)

TABLE 159 GLOBAL SLEEP APNEA DEVICES MARKET BY FACIAL INTERFACES 2021−2027 (%)

TABLE 160 GLOBAL DIAGNOSTIC SLEEP APNEA DEVICES MARKET 2021−2027 ($ MILLION)

TABLE 161 GLOBAL DIAGNOSTIC SLEEP APNEA DEVICES MARKET 2021−2027 (%)

TABLE 162 GLOBAL SLEEP APNEA DEVICES MARKET BY BETWEEN 41 & 60 YEARS 2021−2027 ($ MILLION)

TABLE 163 GLOBAL SLEEP APNEA DEVICES MARKET BY BETWEEN 41 & 60 YEARS 2021−2027 (%)

TABLE 164 GLOBAL SLEEP APNEA DEVICES MARKET BY 61 YEARS & ABOVE 2021−2027 ($ MILLION)

TABLE 165 GLOBAL SLEEP APNEA DEVICES MARKET BY 61 YEARS & ABOVE 2021−2027 (%)

TABLE 166 GLOBAL SLEEP APNEA DEVICES MARKET BY BELOW 40 YEARS 2021−2027 ($ MILLION)

TABLE 167 GLOBAL SLEEP APNEA DEVICES MARKET BY BELOW 40 YEARS 2021−2027 (%)

TABLE 168 GLOBAL SLEEP APNEA DEVICES MARKET BY MALES 2021−2027 ($ MILLION)

TABLE 169 GLOBAL SLEEP APNEA DEVICES MARKET BY MALES 2021−2027 (%)

TABLE 170 GLOBAL SLEEP APNEA DEVICES MARKET BY FEMALES 2021−2027 ($ MILLION)

TABLE 171 GLOBAL SLEEP APNEA DEVICES MARKET BY FEMALES 2021−2027 (%)

TABLE 172 GLOBAL SLEEP APNEA DEVICES MARKET BY SLEEP CLINICS/LABS 2021−2027 ($ MILLION)

TABLE 173 GLOBAL SLEEP APNEA DEVICES MARKET BY SLEEP CLINICS/LABS 2021−2027 (%)

TABLE 174 GLOBAL SLEEP APNEA DEVICES MARKET BY HOME HEALTHCARE SETTINGS 2021−2027 ($ MILLION)

TABLE 175 GLOBAL SLEEP APNEA DEVICES MARKET BY HOME HEALTHCARE SETTINGS 2021−2027 (%)

TABLE 176 GLOBAL SLEEP APNEA DEVICES MARKET BY HOSPITALS 2021−2027 ($ MILLION)

TABLE 177 GLOBAL SLEEP APNEA DEVICES MARKET BY HOSPITALS 2021−2027 (%)

TABLE 178 GLOBAL SLEEP APNEA DEVICES MARKET BY OTHER END-USERS 2021−2027 ($ MILLION)

TABLE 179 GLOBAL SLEEP APNEA DEVICES MARKET BY OTHER END-USERS 2021−2027 (%)

Select a license type that suits your business needs

single-user Single User Licence
$4200.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4999.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5999.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$2000.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Interested in data center portfolio for this report?
Click here

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date